Drug Kinetics – Products

Access this exclusive compendium for a selection of Technology Networks’ most popular content in this rapidly developing topic area including infographics, listicles, talk recordings and more.

Avacta Group plc has announced that the fifth dose escalation cohort in the ALS-6000-101 dose escalation Phase 1 clinical trial to evaluate the safety and tolerability of AVA6000 has been completed successfully.

Torx ® Software Limited, announces the release of Torx 2.0, extending the platform’s scientific reach and capabilities to deliver unrivale seamless integration across the drug discovery Design-Make-Test-Analyze (DMTA) cycle.

Revvity, Inc announced the launch of its Signals Research Suite, a unified, cloud-native SaaS platform that drives scientific collaboration across R&D disciplines from drug discovery to specialty chemicals material development.

This application note demonstrates how reliable kinetics and affinity can be obtained from single measurement data, increasing sample throughput and saving sample material.

Designing and performing assays that accurately measure the binding kinetics of biomolecular interactions requires highly technical skills. Hence, such methods can feel out of reach for many scientists.

SCIEX, celebrates the opening of the Echo® MS Center of Excellence.

Label-free biosensor technologies have emerged as a promising approach to identify high-value hits with a strong likelihood of success as a therapeutic. Unlike traditional approaches of drug discovery, they are fast, sensitive, and come with improved success rates towards high-value drug candidates.

This compendium serves as a user-friendly reference for assay design on both bio-layer interferometry (BLI) and surface plasmon resonance (SPR) systems.

Gyros Protein Technologies AB has announced the introduction of Gyrolab® Generic Cyno Anti-Drug Antibodies Kit Reagents, for the detection of circulating immune complexes of human IgG with cyno anti-human IgG.